contraindications for glp 1 agonists include GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions Endoscopy and Applications for Gastrointestinal Disease Treatment Non-insulin injectable antidiabetic drugs -
Description
doi: 10.2337/diabetes.47.5.764

TABLE 1 Primers used for RT-qPCR

Start with basic movements, focus on consistency, and consult a healthcare provider before beginning any new exercise regimen
In the SURPASS-2 trial, patients with obesity and T2D who received tirzeapatide (5 mg weekly) achieved greater HbA1c and body weight reductions than those receiving semaglutide (1 mg weekly) during the 40 week study (64) despite comparable putative GLP-1R occupancy at these doses (65)

All this translates into an improvement in glycemic control and dyslipidemia, a reduction in blood pressure, weight, and ectopic visceral fat deposits, as well as inflammation and coagulation, which could translate into greater cardiovasculorenal protection with the use of these drugs

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (PIONEER 6)
